159 related articles for article (PubMed ID: 34301197)
1. Autosomal recessive hyper-IgE syndrome caused by DOCK8 gene mutation with new clinical features: a case report.
Yang J; Liu Y
BMC Neurol; 2021 Jul; 21(1):288. PubMed ID: 34301197
[TBL] [Abstract][Full Text] [Related]
2. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.
Engelhardt KR; Gertz ME; Keles S; Schäffer AA; Sigmund EC; Glocker C; Saghafi S; Pourpak Z; Ceja R; Sassi A; Graham LE; Massaad MJ; Mellouli F; Ben-Mustapha I; Khemiri M; Kilic SS; Etzioni A; Freeman AF; Thiel J; Schulze I; Al-Herz W; Metin A; Sanal Ö; Tezcan I; Yeganeh M; Niehues T; Dueckers G; Weinspach S; Patiroglu T; Unal E; Dasouki M; Yilmaz M; Genel F; Aytekin C; Kutukculer N; Somer A; Kilic M; Reisli I; Camcioglu Y; Gennery AR; Cant AJ; Jones A; Gaspar BH; Arkwright PD; Pietrogrande MC; Baz Z; Al-Tamemi S; Lougaris V; Lefranc G; Megarbane A; Boutros J; Galal N; Bejaoui M; Barbouche MR; Geha RS; Chatila TA; Grimbacher B
J Allergy Clin Immunol; 2015 Aug; 136(2):402-12. PubMed ID: 25724123
[TBL] [Abstract][Full Text] [Related]
3. DOCK8 mutation diagnosed using whole-exome sequencing of the dried blood spot-derived DNA: a case report of an Iraqi girl diagnosed in Japan.
Al-Kzayer LFY; Al-Aradi HMH; Shigemura T; Sano K; Tanaka M; Hamada M; Ali KH; Aldaghir OM; Nakazawa Y; Okuno Y
BMC Med Genet; 2019 Jun; 20(1):114. PubMed ID: 31242861
[TBL] [Abstract][Full Text] [Related]
4. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
[TBL] [Abstract][Full Text] [Related]
5. A novel large deletion of the DOCK8 gene in a Chinese family with autosomal-recessive hyper-IgE syndrome.
Xue L; Yang Y; Wang S
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):599-601. PubMed ID: 24673638
[TBL] [Abstract][Full Text] [Related]
6. A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families.
Guo M; Ma Y; Cai K; Liu X; Liu W; Wang F; Qu N; Liu S
Immunogenetics; 2024 Jun; 76(3):165-173. PubMed ID: 38587548
[TBL] [Abstract][Full Text] [Related]
7. Exome-first Approach Identified Novel Homozygous Dedicator of Cytokinesis 8 (DOCK8) Mutations in Three Unrelated Iranian Pedigrees Suspected with Hyper-IgE Syndrome.
Aghebati-Maleki A; Shahani T; Momen T; Alyasin S; Changi-Ashtiani M; Biglari A; Shahrooei M; Javanian AS; Amini S; Bossuyt X; Rokni-Zadeh H
Iran J Allergy Asthma Immunol; 2020 Apr; 19(2):193-199. PubMed ID: 32372632
[TBL] [Abstract][Full Text] [Related]
8. [Hyper-IgE syndromes].
He YY; Liu B; Xiao XP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
[TBL] [Abstract][Full Text] [Related]
9. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
[TBL] [Abstract][Full Text] [Related]
10. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
11. Novel DOCK8 gene mutations lead to absence of protein expression in patients with hyper-IgE syndrome.
Qin T; An Y; Liu C; Wu J; Dai R; Liu D; Li X; Jiang L; Wu D; Tang X; Song W; Wang T; Zhao X
Immunol Res; 2016 Feb; 64(1):260-71. PubMed ID: 26659092
[TBL] [Abstract][Full Text] [Related]
12. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
13. Ten-year follow-up of a DOCK8-deficient child with features of systemic lupus erythematosus.
Jouhadi Z; Khadir K; Ailal F; Bouayad K; Nadifi S; Engelhardt KR; Grimbacher B
Pediatrics; 2014 Nov; 134(5):e1458-63. PubMed ID: 25332498
[TBL] [Abstract][Full Text] [Related]
14. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
Deng Y; Li T; Xie X; Xia D; Ding L; Xiang H; Ma JJ; Li W
Medicine (Baltimore); 2019 Feb; 98(6):e14003. PubMed ID: 30732127
[TBL] [Abstract][Full Text] [Related]
15. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
16. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
[TBL] [Abstract][Full Text] [Related]
17. Hyper IgE syndromes: A clinical approach.
Gharehzadehshirazi A; Amini A; Rezaei N
Clin Immunol; 2022 Apr; 237():108988. PubMed ID: 35351598
[TBL] [Abstract][Full Text] [Related]
18. An update on the hyper-IgE syndromes.
Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
[TBL] [Abstract][Full Text] [Related]
19. Somatic alterations compromised molecular diagnosis of DOCK8 hyper-IgE syndrome caused by a novel intronic splice site mutation.
Hagl B; Spielberger BD; Thoene S; Bonnal S; Mertes C; Winter C; Nijman IJ; Verduin S; Eberherr AC; Puel A; Schindler D; Ruland J; Meitinger T; Gagneur J; Orange JS; van Gijn ME; Renner ED
Sci Rep; 2018 Nov; 8(1):16719. PubMed ID: 30425284
[TBL] [Abstract][Full Text] [Related]
20. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
